Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jennifer Richer

Concepts (414)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Triple Negative Breast Neoplasms
14
2023
164
6.490
 Why?
Receptors, Androgen
13
2023
134
5.600
 Why?
Breast Neoplasms
43
2022
1965
4.270
 Why?
MicroRNAs
17
2018
637
4.110
 Why?
Androgen Receptor Antagonists
8
2021
32
2.680
 Why?
Anoikis
7
2021
35
2.460
 Why?
Gene Expression Regulation, Neoplastic
34
2021
1167
2.460
 Why?
Estrogen Receptor alpha
6
2022
126
2.070
 Why?
Receptors, Progesterone
24
2016
325
2.030
 Why?
Cell Line, Tumor
36
2023
2851
1.970
 Why?
Phenylthiohydantoin
6
2017
40
1.910
 Why?
Receptors, Estrogen
14
2020
387
1.510
 Why?
Tryptophan Oxygenase
3
2018
22
1.370
 Why?
Tryptophan
2
2018
139
1.230
 Why?
Progesterone
16
2014
242
1.100
 Why?
Progestins
6
2014
77
1.050
 Why?
Tamoxifen
10
2016
198
1.040
 Why?
Ovarian Neoplasms
4
2020
420
1.030
 Why?
Neoplastic Stem Cells
3
2017
336
0.940
 Why?
Ribonuclease III
2
2016
33
0.940
 Why?
Epithelial Cells
3
2022
963
0.930
 Why?
DEAD-box RNA Helicases
2
2016
56
0.920
 Why?
Drug Resistance, Neoplasm
7
2020
671
0.910
 Why?
Biomarkers, Tumor
7
2021
1059
0.900
 Why?
Epithelial-Mesenchymal Transition
5
2018
176
0.900
 Why?
Receptor, ErbB-2
4
2017
320
0.870
 Why?
Cell Proliferation
14
2021
2275
0.850
 Why?
Kallikreins
1
2021
33
0.830
 Why?
Adipokines
1
2021
46
0.810
 Why?
Gene Expression Profiling
11
2018
1597
0.810
 Why?
Neoplasm Recurrence, Local
6
2023
900
0.800
 Why?
Endometrial Neoplasms
6
2011
144
0.780
 Why?
Prostate-Specific Antigen
1
2021
156
0.770
 Why?
Membrane Transport Proteins
1
2021
137
0.760
 Why?
Trophoblasts
1
2022
170
0.760
 Why?
RNA, Long Noncoding
2
2022
161
0.750
 Why?
Immunohistochemistry
8
2017
1691
0.730
 Why?
Transcription Factors
13
2023
1570
0.730
 Why?
Cell Movement
9
2020
896
0.730
 Why?
Androgen Antagonists
3
2017
70
0.730
 Why?
Transforming Growth Factor beta1
1
2021
164
0.720
 Why?
Pulmonary Alveoli
1
2022
384
0.710
 Why?
Alternative Splicing
2
2018
193
0.710
 Why?
Mammary Glands, Animal
4
2022
124
0.710
 Why?
Homeodomain Proteins
5
2014
468
0.700
 Why?
Repressor Proteins
6
2018
377
0.690
 Why?
Cell Cycle
4
2021
550
0.680
 Why?
Female
57
2023
61565
0.660
 Why?
RNA Splicing Factors
1
2018
50
0.650
 Why?
Mammary Neoplasms, Experimental
3
2017
63
0.640
 Why?
Up-Regulation
7
2020
872
0.630
 Why?
Humans
83
2023
118974
0.610
 Why?
Mice
23
2021
15520
0.610
 Why?
Animals
38
2022
33381
0.610
 Why?
Xenograft Model Antitumor Assays
8
2021
740
0.610
 Why?
Nitriles
6
2017
155
0.590
 Why?
Benzamides
6
2017
176
0.590
 Why?
Carcinoma, Endometrioid
2
2008
47
0.590
 Why?
Lactation
2
2022
160
0.580
 Why?
Gonadal Steroid Hormones
1
2018
122
0.570
 Why?
Lipogenesis
1
2016
66
0.560
 Why?
Paclitaxel
3
2017
195
0.560
 Why?
Antibody Specificity
1
2016
184
0.550
 Why?
Antineoplastic Agents
6
2018
1974
0.540
 Why?
Receptor, trkB
2
2012
28
0.540
 Why?
Receptors, Aryl Hydrocarbon
1
2015
36
0.530
 Why?
Fatty Acid Synthase, Type I
1
2014
5
0.510
 Why?
TOR Serine-Threonine Kinases
1
2017
369
0.490
 Why?
RNA Interference
3
2015
460
0.480
 Why?
Apoptosis
11
2020
2484
0.480
 Why?
Antibodies
1
2016
392
0.480
 Why?
Metformin
2
2014
295
0.470
 Why?
Receptors, Steroid
2
2010
54
0.470
 Why?
CD8-Positive T-Lymphocytes
1
2018
702
0.460
 Why?
Kynurenine
3
2018
81
0.450
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2020
1390
0.450
 Why?
Gene Expression Regulation
8
2016
2445
0.440
 Why?
Chromatin
1
2016
441
0.440
 Why?
Neoadjuvant Therapy
2
2020
333
0.430
 Why?
Kruppel-Like Transcription Factors
1
2012
56
0.420
 Why?
Signal Transduction
17
2015
4709
0.420
 Why?
Sodium-Potassium-Exchanging ATPase
1
2012
46
0.410
 Why?
Disease Progression
6
2018
2490
0.410
 Why?
Antineoplastic Agents, Hormonal
5
2020
143
0.410
 Why?
Endometrium
2
2008
61
0.390
 Why?
Transcriptional Activation
5
2017
348
0.380
 Why?
Mice, SCID
4
2020
333
0.380
 Why?
Cell Transformation, Neoplastic
1
2012
317
0.350
 Why?
Estradiol
6
2016
476
0.350
 Why?
Tubulin Modulators
1
2009
10
0.350
 Why?
Neoplasms
5
2022
2179
0.350
 Why?
Cells
1
2009
24
0.350
 Why?
3' Untranslated Regions
4
2014
142
0.340
 Why?
Uterine Neoplasms
2
2008
76
0.340
 Why?
Cadherins
4
2012
186
0.340
 Why?
Zinc Finger E-box-Binding Homeobox 1
4
2011
25
0.340
 Why?
Dirofilaria immitis
3
2010
3
0.320
 Why?
Mice, Nude
5
2017
663
0.310
 Why?
Feedback, Physiological
2
2021
75
0.300
 Why?
Trastuzumab
2
2017
92
0.300
 Why?
Cell Nucleus
5
2017
580
0.290
 Why?
Microtubules
1
2009
241
0.290
 Why?
MCF-7 Cells
3
2016
111
0.290
 Why?
Transfection
5
2012
888
0.290
 Why?
Epidermal Growth Factor
4
2005
173
0.280
 Why?
Anilides
2
2016
69
0.260
 Why?
Mice, Inbred NOD
3
2020
574
0.250
 Why?
Cell Differentiation
1
2012
1753
0.250
 Why?
Down-Regulation
6
2016
627
0.250
 Why?
Microarray Analysis
2
2016
124
0.250
 Why?
Gene Expression
4
2020
1489
0.240
 Why?
Lung Neoplasms
1
2017
2220
0.240
 Why?
Molecular Targeted Therapy
2
2018
356
0.240
 Why?
Pharmacology, Clinical
1
2023
8
0.230
 Why?
Oligonucleotide Array Sequence Analysis
5
2010
770
0.230
 Why?
Mutation
5
2022
3457
0.230
 Why?
Epigenesis, Genetic
2
2018
539
0.210
 Why?
Mammary Glands, Human
2
2014
61
0.210
 Why?
Tumor Cells, Cultured
11
2020
874
0.210
 Why?
Neoplasm Invasiveness
3
2015
462
0.210
 Why?
Milk Proteins
2
1999
37
0.210
 Why?
NF-E2-Related Factor 2
1
2022
83
0.210
 Why?
Estrogens
3
2020
328
0.200
 Why?
Epithelium
1
2022
305
0.200
 Why?
Neoplastic Cells, Circulating
1
2022
62
0.200
 Why?
Mice, Transgenic
2
2017
2025
0.200
 Why?
Promoter Regions, Genetic
6
2014
1158
0.200
 Why?
Tumor Microenvironment
2
2022
454
0.200
 Why?
Neoplasms, Second Primary
1
2022
93
0.190
 Why?
DNA-Binding Proteins
6
2018
1346
0.190
 Why?
Semaphorins
1
2020
22
0.190
 Why?
Cytoreduction Surgical Procedures
1
2020
40
0.190
 Why?
Respiratory Mucosa
1
2022
254
0.190
 Why?
Neoplasm Proteins
2
2018
401
0.190
 Why?
Immune Tolerance
1
2022
334
0.190
 Why?
Epoxy Compounds
1
2020
33
0.180
 Why?
Androgens
1
2021
167
0.180
 Why?
Transcription, Genetic
9
2012
1323
0.180
 Why?
NF-kappa B
2
2015
670
0.180
 Why?
Gene Knockdown Techniques
2
2020
311
0.180
 Why?
Carnitine O-Palmitoyltransferase
1
2020
47
0.180
 Why?
Pregnancy
3
2022
5691
0.180
 Why?
STAT5 Transcription Factor
3
2014
43
0.180
 Why?
RNA, Messenger
7
2011
2657
0.180
 Why?
Cystadenocarcinoma, Serous
1
2020
49
0.180
 Why?
Chemotherapy, Adjuvant
1
2020
360
0.170
 Why?
RNA, Small Interfering
3
2020
564
0.160
 Why?
Prolactin
1
1998
96
0.160
 Why?
Gene Amplification
1
2018
97
0.160
 Why?
Antigens, CD
1
2020
460
0.160
 Why?
Immunoblotting
3
2010
307
0.160
 Why?
Lymphocytes, Tumor-Infiltrating
1
2018
112
0.160
 Why?
Endometrial Hyperplasia
2
2008
16
0.160
 Why?
Binding Sites
5
2016
1224
0.150
 Why?
Mammary Tumor Virus, Mouse
1
2017
41
0.150
 Why?
Everolimus
1
2017
64
0.150
 Why?
Fatty Acids
1
2020
407
0.150
 Why?
Histone Acetyltransferases
3
2006
53
0.150
 Why?
Dihydrotestosterone
1
2017
39
0.150
 Why?
Cluster Analysis
4
2008
481
0.150
 Why?
Immunity, Cellular
1
2018
270
0.150
 Why?
Estrogen Receptor Modulators
3
2008
19
0.150
 Why?
Neoplasm Transplantation
2
2014
245
0.150
 Why?
Heterografts
1
2017
130
0.150
 Why?
Cyclohexanes
1
2016
22
0.140
 Why?
Tumor Suppressor Proteins
2
2014
289
0.140
 Why?
Carcinogenesis
1
2018
182
0.140
 Why?
Placenta
1
2022
639
0.140
 Why?
Hyaluronan Receptors
2
2014
93
0.140
 Why?
Trans-Activators
4
2006
373
0.140
 Why?
Ovary
1
2017
205
0.140
 Why?
Killer Cells, Natural
1
2018
381
0.140
 Why?
Transplantation, Heterologous
2
2014
194
0.130
 Why?
Phosphoproteins
2
2008
308
0.130
 Why?
Neoplasm Metastasis
2
2015
544
0.130
 Why?
Hormones
1
2015
135
0.130
 Why?
Drug Delivery Systems
1
2017
306
0.130
 Why?
Tosyl Compounds
1
2014
14
0.120
 Why?
Genes, Reporter
2
2012
270
0.120
 Why?
Sarcoma, Ewing
1
2015
65
0.120
 Why?
Ligands
6
2023
567
0.120
 Why?
HEK293 Cells
1
2016
625
0.120
 Why?
PTEN Phosphohydrolase
1
2015
143
0.120
 Why?
Protein Transport
1
2015
412
0.120
 Why?
Disease Models, Animal
2
2021
3730
0.120
 Why?
In Situ Hybridization
2
2010
311
0.120
 Why?
Cysteine Proteinase Inhibitors
1
1993
50
0.110
 Why?
Cellular Reprogramming
1
2014
85
0.110
 Why?
Clinical Trials as Topic
1
2018
969
0.110
 Why?
Ketones
1
1993
45
0.110
 Why?
Cell Adhesion
2
2012
443
0.110
 Why?
Cells, Cultured
2
2016
4077
0.110
 Why?
Neurotrophin 3
1
2012
15
0.110
 Why?
Phosphatidylinositol 3-Kinases
1
2015
341
0.110
 Why?
Autocrine Communication
1
2012
42
0.110
 Why?
Aromatase Inhibitors
2
2014
52
0.110
 Why?
Metalloendopeptidases
1
1992
56
0.110
 Why?
Mice, Inbred C57BL
2
2016
4908
0.110
 Why?
Nuclear Proteins
5
2000
597
0.110
 Why?
Cysteine Endopeptidases
1
1992
61
0.110
 Why?
Transduction, Genetic
1
2012
116
0.110
 Why?
Middle Aged
6
2016
27617
0.110
 Why?
Disease-Free Survival
1
2014
649
0.110
 Why?
Gene Silencing
2
2014
177
0.100
 Why?
Tubulin
1
2012
122
0.100
 Why?
Luciferases
1
2012
143
0.100
 Why?
Tumor Burden
1
2012
274
0.100
 Why?
Carrier Proteins
2
2023
726
0.100
 Why?
Zinc Finger E-box Binding Homeobox 2
1
2011
5
0.100
 Why?
Tissue Array Analysis
2
2008
52
0.100
 Why?
Receptors, Leptin
1
2011
27
0.100
 Why?
Protein Biosynthesis
2
2012
397
0.100
 Why?
Predictive Value of Tests
1
2016
1868
0.100
 Why?
GTPase-Activating Proteins
1
2011
71
0.100
 Why?
Fibronectins
1
2011
114
0.090
 Why?
Microfilament Proteins
1
2011
134
0.090
 Why?
Cell Transdifferentiation
1
2010
32
0.090
 Why?
HeLa Cells
5
2006
583
0.090
 Why?
Retinoid X Receptors
1
2010
38
0.090
 Why?
Enzyme Inhibitors
2
2008
827
0.090
 Why?
Cyclins
3
1999
82
0.090
 Why?
Protein Isoforms
4
2006
345
0.090
 Why?
Breast
2
2022
140
0.090
 Why?
Lung
1
2022
3664
0.090
 Why?
DNA, Complementary
4
2008
268
0.090
 Why?
Real-Time Polymerase Chain Reaction
1
2010
333
0.090
 Why?
Inflammation
1
2020
2566
0.090
 Why?
Reverse Transcriptase Polymerase Chain Reaction
6
2010
982
0.090
 Why?
Cell Line, Transformed
1
2009
136
0.090
 Why?
Receptors, Cytoplasmic and Nuclear
2
2023
195
0.080
 Why?
Reproducibility of Results
1
2016
2874
0.080
 Why?
Perilipin-1
1
2008
16
0.080
 Why?
S100 Proteins
1
2008
35
0.080
 Why?
Glucose
1
2013
953
0.080
 Why?
Leiomyoma
1
2008
45
0.080
 Why?
Drug Interactions
1
2009
352
0.080
 Why?
Hysterectomy
1
2008
117
0.080
 Why?
Receptor, IGF Type 1
1
2006
59
0.070
 Why?
Survival Rate
2
2020
1720
0.070
 Why?
Aged
4
2016
19657
0.070
 Why?
Stem Cells
1
2010
559
0.070
 Why?
Hypoglycemic Agents
1
2013
1032
0.070
 Why?
Molecular Sequence Data
6
2010
2871
0.070
 Why?
Precancerous Conditions
1
2006
160
0.060
 Why?
Thromboplastin
1
2004
68
0.060
 Why?
Neoplasm Staging
1
2008
1223
0.060
 Why?
Protein Binding
4
2010
1975
0.060
 Why?
Cyclin-Dependent Kinase Inhibitor p21
3
1999
109
0.060
 Why?
Obesity
1
2017
2746
0.060
 Why?
Ovariectomy
2
2017
124
0.060
 Why?
Intracellular Signaling Peptides and Proteins
1
2006
404
0.060
 Why?
Postmenopause
3
2017
305
0.060
 Why?
Amino Acid Sequence
4
2010
2071
0.060
 Why?
Core Binding Factor Alpha 2 Subunit
1
2023
30
0.060
 Why?
Adult
4
2016
31512
0.060
 Why?
Prognosis
2
2020
3443
0.050
 Why?
Immune Evasion
1
2022
48
0.050
 Why?
ErbB Receptors
1
2005
569
0.050
 Why?
Fibroblasts
1
2006
842
0.050
 Why?
Larva
2
1993
213
0.050
 Why?
Promegestone
4
2005
33
0.050
 Why?
Biology
1
2022
83
0.050
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
2
1999
175
0.050
 Why?
Mifepristone
2
2000
65
0.050
 Why?
Treatment Outcome
1
2015
9342
0.050
 Why?
Drug Resistance
2
2000
167
0.050
 Why?
Vascular Endothelial Growth Factor A
1
2004
527
0.050
 Why?
GPI-Linked Proteins
1
2020
56
0.050
 Why?
Young Adult
1
2016
10793
0.050
 Why?
Mammals
1
2022
253
0.050
 Why?
Exons
2
1999
307
0.050
 Why?
Antigens, Nuclear
1
2000
18
0.050
 Why?
Postpartum Period
1
2022
271
0.050
 Why?
Poly(ADP-ribose) Polymerases
1
2000
87
0.050
 Why?
Adenocarcinoma
1
2006
812
0.040
 Why?
Aged, 80 and over
2
2008
6561
0.040
 Why?
Chromosomes, Human, Pair 17
1
1999
63
0.040
 Why?
Receptor Cross-Talk
1
1998
22
0.040
 Why?
p300-CBP Transcription Factors
1
2018
15
0.040
 Why?
DNA Helicases
1
2000
131
0.040
 Why?
Immunological Synapses
1
2018
18
0.040
 Why?
STAT1 Transcription Factor
1
1998
69
0.040
 Why?
Intercellular Adhesion Molecule-1
1
2018
175
0.040
 Why?
Drug Synergism
1
1998
339
0.040
 Why?
Oxygenases
1
1997
10
0.040
 Why?
Proto-Oncogene Proteins c-fos
1
1998
193
0.040
 Why?
Receptor, ErbB-3
1
2017
42
0.040
 Why?
Biological Transport
1
1998
382
0.040
 Why?
Cell Culture Techniques
1
2020
356
0.040
 Why?
Combined Modality Therapy
1
2020
1166
0.040
 Why?
Mitogen-Activated Protein Kinases
1
1998
298
0.040
 Why?
Ribosomal Proteins
1
1997
68
0.040
 Why?
Carcinogens
1
1997
108
0.040
 Why?
STAT3 Transcription Factor
1
1998
189
0.040
 Why?
Oxidation-Reduction
1
2020
940
0.040
 Why?
Analysis of Variance
2
2005
1293
0.040
 Why?
Saccharomyces cerevisiae Proteins
1
2000
348
0.040
 Why?
Steroids
1
2017
153
0.040
 Why?
Male
2
2021
57801
0.040
 Why?
Sequence Alignment
2
2010
336
0.040
 Why?
Gene Expression Regulation, Enzymologic
1
2017
290
0.040
 Why?
Muscle, Smooth, Vascular
1
1999
454
0.040
 Why?
Histones
2
2014
552
0.030
 Why?
Chromatography, Liquid
1
2017
355
0.030
 Why?
Nuclear Receptor Co-Repressor 1
3
2000
16
0.030
 Why?
Proto-Oncogene Protein c-fli-1
1
2015
16
0.030
 Why?
Mice, Inbred BALB C
1
2017
1206
0.030
 Why?
Keratin-5
1
2014
47
0.030
 Why?
Base Sequence
3
2008
2159
0.030
 Why?
Nuclear Receptor Coactivator 1
2
2006
10
0.030
 Why?
Mass Spectrometry
1
2017
681
0.030
 Why?
Genetic Variation
1
1999
926
0.030
 Why?
Testosterone
1
2017
351
0.030
 Why?
Interleukin-6
1
2017
688
0.030
 Why?
Dipeptides
1
1993
51
0.030
 Why?
Adipose Tissue
1
2017
606
0.030
 Why?
DNA Primers
2
2008
533
0.030
 Why?
Chromatography
1
1992
25
0.030
 Why?
Microscopy, Electron
1
1993
413
0.030
 Why?
Elastin
1
1992
77
0.030
 Why?
Hydrolysis
1
1992
176
0.030
 Why?
Protease Inhibitors
1
1992
102
0.030
 Why?
Follow-Up Studies
1
2020
4596
0.030
 Why?
Blotting, Northern
1
2010
194
0.020
 Why?
Glycoproteins
1
1992
319
0.020
 Why?
Cell Size
1
2010
86
0.020
 Why?
Oligopeptides
1
1992
252
0.020
 Why?
Cell Dedifferentiation
1
2010
30
0.020
 Why?
COS Cells
2
2003
184
0.020
 Why?
DNA, Helminth
1
2010
16
0.020
 Why?
Collagen
1
1992
433
0.020
 Why?
Electrophoretic Mobility Shift Assay
1
2010
76
0.020
 Why?
NIH 3T3 Cells
1
2010
139
0.020
 Why?
DNA Methylation
1
2014
503
0.020
 Why?
Nuclear Receptor Co-Repressor 2
2
2000
14
0.020
 Why?
Matrix Metalloproteinase 11
1
2008
4
0.020
 Why?
Extracellular Matrix
1
1992
446
0.020
 Why?
Rats
1
2017
5392
0.020
 Why?
Phosphorylation
2
2005
1633
0.020
 Why?
RNA, Neoplasm
1
2008
77
0.020
 Why?
Myometrium
1
2008
35
0.020
 Why?
Dose-Response Relationship, Drug
2
2005
1945
0.020
 Why?
Cell Division
2
2000
776
0.020
 Why?
DNA, Neoplasm
1
2008
154
0.020
 Why?
Androstadienes
1
2008
94
0.020
 Why?
Trypan Blue
1
2006
4
0.020
 Why?
Comet Assay
1
2006
15
0.020
 Why?
Nuclear Receptor Coactivator 3
1
2006
6
0.020
 Why?
Sequence Analysis, DNA
1
2010
755
0.020
 Why?
Biomarkers
1
2017
3588
0.020
 Why?
Membrane Potential, Mitochondrial
1
2006
56
0.020
 Why?
Insulin Receptor Substrate Proteins
1
2006
58
0.020
 Why?
Radiation, Ionizing
1
2006
74
0.020
 Why?
Staining and Labeling
1
2006
146
0.020
 Why?
Proteasome Endopeptidase Complex
1
2006
139
0.020
 Why?
Mutant Proteins
1
2006
100
0.020
 Why?
Androstenes
1
2005
11
0.020
 Why?
Amino Acid Motifs
1
2006
200
0.020
 Why?
Neuroblastoma
1
2006
135
0.020
 Why?
Recombinant Fusion Proteins
2
2000
653
0.020
 Why?
Medroxyprogesterone Acetate
1
2005
30
0.020
 Why?
Caspase 3
1
2006
243
0.020
 Why?
Levonorgestrel
1
2005
32
0.020
 Why?
Desogestrel
1
2005
41
0.020
 Why?
Protein Structure, Secondary
1
2006
338
0.020
 Why?
DNA Repair
1
2006
198
0.020
 Why?
Alkaline Phosphatase
1
2005
157
0.020
 Why?
Sucrose
1
2004
104
0.020
 Why?
Insulin-Like Growth Factor I
1
2006
287
0.020
 Why?
Adenosine Triphosphate
1
2006
439
0.020
 Why?
DNA Damage
1
2006
357
0.020
 Why?
Reactive Oxygen Species
1
2006
576
0.010
 Why?
Protein Structure, Tertiary
1
2006
823
0.010
 Why?
Microscopy, Confocal
1
2004
314
0.010
 Why?
Mutagenesis
1
2003
176
0.010
 Why?
Progesterone Congeners
1
2002
15
0.010
 Why?
Sequence Homology, Amino Acid
1
2003
372
0.010
 Why?
Uterus
1
2003
194
0.010
 Why?
Dimerization
1
2002
183
0.010
 Why?
Cell Survival
1
2004
1047
0.010
 Why?
Plasmids
1
2002
355
0.010
 Why?
DNA-Activated Protein Kinase
1
2000
10
0.010
 Why?
Ku Autoantigen
1
2000
12
0.010
 Why?
Antibodies, Monoclonal
1
2006
1284
0.010
 Why?
Glutathione Transferase
1
2000
97
0.010
 Why?
Recombinant Proteins
1
2003
1308
0.010
 Why?
Culture Techniques
1
1999
80
0.010
 Why?
Methionine
1
2000
145
0.010
 Why?
RNA
1
2005
833
0.010
 Why?
Growth Substances
1
1999
136
0.010
 Why?
Cricetinae
1
1999
262
0.010
 Why?
Estrogen Receptor beta
1
1999
37
0.010
 Why?
Phosphotyrosine
1
1998
37
0.010
 Why?
Peptide Fragments
1
2003
702
0.010
 Why?
Receptors, Growth Factor
1
1998
50
0.010
 Why?
Premenopause
1
1999
108
0.010
 Why?
Sp1 Transcription Factor
1
1998
23
0.010
 Why?
JNK Mitogen-Activated Protein Kinases
1
1998
155
0.010
 Why?
Estrogen Antagonists
1
1998
39
0.010
 Why?
Chromosome Mapping
1
1999
510
0.010
 Why?
Mitogen-Activated Protein Kinase 3
1
1998
154
0.010
 Why?
Mitogen-Activated Protein Kinase 1
1
1998
173
0.010
 Why?
Isomerism
1
1997
43
0.010
 Why?
p38 Mitogen-Activated Protein Kinases
1
1998
285
0.010
 Why?
Leucine Zippers
1
1997
16
0.010
 Why?
Gene Deletion
1
1999
361
0.010
 Why?
Yeasts
1
1997
52
0.010
 Why?
Autoantigens
1
2000
397
0.010
 Why?
Blotting, Western
1
1998
1194
0.010
 Why?
Polymerase Chain Reaction
1
1998
1012
0.010
 Why?
Time Factors
1
2004
6412
0.010
 Why?
Cell Line
1
1998
2707
0.010
 Why?
Cytokines
1
1999
1900
0.010
 Why?
Models, Biological
1
1998
1715
0.010
 Why?
Richer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (414) concept(s)
_
Co-Authors Expand Description
See all (53) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)